Back close

Mitogen Activated Protein Kinase 4 of Leishmania Parasite as a Therapeutic Target

Publication Type : Journal Article

Thematic Areas : Nanosciences and Molecular Medicine

Publisher : European Journal of Medicinal Chemistry

Source : European Journal of Medicinal Chemistry, Volume 45, Number 12, p.5662 - 5670 (2010)

Url :

Keywords : Chemotherapy, Docking, Mitogen-Activated Protein Kinases, Motif, virtual screening

Campus : Kochi

School : Center for Nanosciences

Center : Amrita Center for Nanosciences and Molecular Medicine Move, Nanosciences

Department : Nanosciences and Molecular Medicine

Year : 2010

Abstract : Protein kinases are important regulators of many different cellular processes such as transcriptional control, cell cycle progression and differentiation, and have drawn much attention as potential drug targets. Leishmania mexicana mitogen-activated protein kinase 4 (LmxMPK4) is crucial for the survival of the parasite. As the crystal structure of the enzyme is not known, we have used bioinformatics techniques to model LmxMPK4 structure. The current study reveals conservation of all sequence and structural motifs of LmxMPK4. Study shows mitogen-activated protein kinases are highly conserved throughout different Leishmania species and significant divergence is observed towards mammalian mitogen-activated protein kinases. Additionally, using virtual docking methods, we have identified inhibitors for LmxMPK4. The sequence and structure analysis results were helpful in identifying the ligand binding sites and molecular function of the Leishmania specific mitogen-activated protein kinase

Cite this Research Publication : P. Saravanan, Venkatesan, S. K., Dr. Gopi Mohan C., Patra, S., and Dubey, V. Kumar, “Mitogen Activated Protein Kinase 4 of Leishmania Parasite as a Therapeutic Target”, European Journal of Medicinal Chemistry, vol. 45, pp. 5662 - 5670, 2010.

Admissions Apply Now